On April 28, 2025, Sigachi Industries Ltd announced that its subsidiary Sigachi MENA FZCO signed a Memorandum of Understanding with Respilon Group s.r.o to develop advanced nanofiber-based drug delivery technologies, aiming to improve therapeutic outcomes.